BidaskClub cut shares of Hologic (NASDAQ:HOLX) from a buy rating to a hold rating in a research report released on Saturday morning, BidAskClub reports.

HOLX has been the topic of several other research reports. ValuEngine raised shares of China Southern Airlines from a sell rating to a hold rating in a research note on Tuesday, June 11th. TheStreet lowered shares of ZTO Express (Cayman) from a b+ rating to a c rating in a research note on Wednesday, May 1st. BTIG Research raised their target price on shares of Yum! Brands to $114.00 and gave the company a buy rating in a research note on Thursday, May 2nd. Needham & Company LLC reduced their target price on shares of to $10.00 and set a buy rating on the stock in a research note on Wednesday, July 10th. Finally, Zacks Investment Research raised shares of Hudson Technologies from a sell rating to a hold rating in a research note on Wednesday, May 29th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the company. Hologic currently has an average rating of Hold and a consensus price target of $45.02.

Shares of NASDAQ HOLX opened at $47.08 on Friday. The company has a market cap of $12.68 billion, a price-to-earnings ratio of 21.11, a PEG ratio of 2.18 and a beta of 0.72. The company has a quick ratio of 1.02, a current ratio of 1.45 and a debt-to-equity ratio of 1.31. Hologic has a 1 year low of $37.47 and a 1 year high of $49.78. The company has a 50-day simple moving average of $47.23.

Hologic (NASDAQ:HOLX) last issued its earnings results on Wednesday, May 1st. The medical equipment provider reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.01. The company had revenue of $818.40 million for the quarter, compared to analyst estimates of $806.99 million. Hologic had a negative net margin of 0.32% and a positive return on equity of 26.73%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.53 EPS. As a group, equities research analysts expect that Hologic will post 2.42 EPS for the current year.

In related news, insider Peter J. Valenti III sold 4,545 shares of Hologic stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $44.07, for a total transaction of $200,298.15. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.90% of the stock is owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in HOLX. Dimensional Fund Advisors LP boosted its stake in Hologic by 0.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,166,835 shares of the medical equipment provider’s stock worth $89,051,000 after acquiring an additional 8,284 shares during the last quarter. Natixis Advisors L.P. lifted its stake in Hologic by 18.0% in the fourth quarter. Natixis Advisors L.P. now owns 131,087 shares of the medical equipment provider’s stock valued at $5,387,000 after buying an additional 19,982 shares in the last quarter. Geode Capital Management LLC lifted its stake in Hologic by 5.3% in the fourth quarter. Geode Capital Management LLC now owns 3,805,329 shares of the medical equipment provider’s stock valued at $156,146,000 after buying an additional 190,788 shares in the last quarter. Menta Capital LLC bought a new position in Hologic in the fourth quarter valued at approximately $321,000. Finally, Bronfman E.L. Rothschild L.P. lifted its stake in Hologic by 90.1% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,194 shares of the medical equipment provider’s stock valued at $49,000 after buying an additional 566 shares in the last quarter. 96.38% of the stock is currently owned by institutional investors and hedge funds.

About Hologic

Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Recommended Story: How to Trade Using Analysts Ratings

Analyst Recommendations for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.